Brief: Regis Healthcare Says Assessing Impact Of Aged Care Approval Rounds Removal

Regis Healthcare

12/12/2021 22:55

Dec 13 (Reuters) - Regis Healthcare Ltd  REG.AX :
    * NON-CASH IMPACT OF REMOVAL OF AGED CARE APPROVAL ROUNDS
    * TALKS WITH DEPARTMENT OF HEALTH ONGOING ON PRACTICAL
IMPLICATIONS OF DISCONTINUATION OF AGED CARE APPROVAL ROUNDS
    * EXPECTS TO AMORTISE VALUE OF BED LICENCES ON A STRAIGHT
LINE
BASIS OVER THEIR REMAINING ECONOMIC LIFE TO 1 JULY 2024
    * SEES REMOVAL OF AGED CARE APPROVAL ROUNDS RESULT IN AFTER
TAX
AMORTISATION EXPENSE FOR FY22 A$43.5 MILLION, NET OF TAX (9
MONTHS)
    * SEES REMOVAL OF AGED CARE APPROVAL ROUNDS RESULT IN AFTER
TAX
AMORTISATION EXPENSE FOR FY23 OF A$58 MILLION, NET OF TAX
    * NOT EXPECTED NON-CASH AMORTISATION OF BED LICENCES WILL,
IN
ITSELF, LIMIT ABILITY TO PAY DIVIDENDS
    * SEES REMOVAL OF AGED CARE APPROVAL ROUNDS RESULT IN AN
AFTER TAX
AMORTISATION EXPENSE FOR FY24 OF A$58.0 MILLION, NET OF TAX

Source text for Eikon:  ID:nASX60KwkX 
Further company coverage:  REG.AX 

 ((Reuters.Briefs@thomsonreuters.com;))